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Background: We sought to determine whether gated equilibrium radionuclide angiogram (ERNA) could be used to assess left ventricular (LV) 
function and synchrony in the electrophysiology (EP) laboratory during cardiac resynchronization therapy (CRT). 
Methods: We attempted to acquire ERNA in the EP lab in 13 pts undergoing CRT. We successfully acquired images in 10 pts, in 3 pts images were 
unobtainable due to lack of suitable coronary sinus (CS) branch vein. 3-5 images were acquired per pt, one without pacing, one with RV pacing as 
possible, and 2-4 with pacing at different CS branch vein sites. Assessed on serial study were LV ejection fraction, phase image amplitude and phase, 
standard deviation of phase angle, interventricular synchrony, and unique parameters of intraventricular synchrony derived from phase analysis. All 
pts had baseline ERNA in our nuclear medicine laboratory. 
Results: Studies without pacing in the EP and nuclear labs were comparable in all pts. In all pts there were evident changes in regional contraction 
pattern, phase and amplitude but no significant change in LV ejection fraction between pacing sites. In one case there was dramatic improvement 
with pacing in all parameters compared to baseline. Pts are now being followed for long-term outcomes. 
Conclusion: ERNA evaluation of LV function and synchrony during CRT is safe and feasible. The data 
acquired may aid optimal placement of the LV pacemaker and serve as the earliest guide to CRT outcome.
